Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Balstilimab by Agenus for Esophageal Squamous Cell Carcinoma (ESCC): Likelihood of Approval
Balstilimab is under clinical development by Agenus and currently in Phase III for Esophageal Squamous Cell Carcinoma (ESCC). According to...
Balstilimab by Agenus for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval
Balstilimab is under clinical development by Agenus and currently in Phase III for Head And Neck Squamous Cell Carcinoma (HNSC)....
Balstilimab by Agenus for Adenocarcinoma Of The Gastroesophageal Junction: Likelihood of Approval
Balstilimab is under clinical development by Agenus and currently in Phase III for Adenocarcinoma Of The Gastroesophageal Junction. According to...
Balstilimab by Agenus for Endometrial Cancer: Likelihood of Approval
Balstilimab is under clinical development by Agenus and currently in Phase III for Endometrial Cancer. According to GlobalData, Phase III...
Balstilimab by Agenus for Sarcomas: Likelihood of Approval
Balstilimab is under clinical development by Agenus and currently in Phase III for Sarcomas. According to GlobalData, Phase III drugs...
Balstilimab by Agenus for Bladder Cancer: Likelihood of Approval
Balstilimab is under clinical development by Agenus and currently in Phase III for Bladder Cancer. According to GlobalData, Phase III...
Balstilimab by Agenus for Colorectal Cancer: Likelihood of Approval
Balstilimab is under clinical development by Agenus and currently in Phase III for Colorectal Cancer. According to GlobalData, Phase III...
Balstilimab by Agenus for Prostate Cancer: Likelihood of Approval
Balstilimab is under clinical development by Agenus and currently in Phase III for Prostate Cancer. According to GlobalData, Phase III...
Balstilimab by Agenus for Ovarian Cancer: Likelihood of Approval
Balstilimab is under clinical development by Agenus and currently in Phase III for Ovarian Cancer. According to GlobalData, Phase III...
Balstilimab by Agenus for Breast Cancer: Likelihood of Approval
Balstilimab is under clinical development by Agenus and currently in Phase III for Breast Cancer. According to GlobalData, Phase III...
Balstilimab by Agenus for Synovial Sarcoma: Likelihood of Approval
Balstilimab is under clinical development by Agenus and currently in Phase II for Synovial Sarcoma. According to GlobalData, Phase II...
Balstilimab by Agenus for Fibrosarcoma: Likelihood of Approval
Balstilimab is under clinical development by Agenus and currently in Phase II for Fibrosarcoma. According to GlobalData, Phase II drugs...
Balstilimab by Agenus for Pleomorphic Liposarcoma: Likelihood of Approval
Balstilimab is under clinical development by Agenus and currently in Phase II for Pleomorphic Liposarcoma. According to GlobalData, Phase II...
Balstilimab by Agenus for Round Cell Liposarcoma: Likelihood of Approval
Balstilimab is under clinical development by Agenus and currently in Phase II for Round Cell Liposarcoma. According to GlobalData, Phase...
Balstilimab by Agenus for Myxoid Liposarcoma: Likelihood of Approval
Balstilimab is under clinical development by Agenus and currently in Phase II for Myxoid Liposarcoma. According to GlobalData, Phase II...
Balstilimab by Agenus for Dedifferentiated Liposarcoma: Likelihood of Approval
Balstilimab is under clinical development by Agenus and currently in Phase II for Dedifferentiated Liposarcoma. According to GlobalData, Phase II...
Balstilimab by Agenus for Peripheral Nerve Sheath Tumor (Neurofibrosarcoma): Likelihood of Approval
Balstilimab is under clinical development by Agenus and currently in Phase II for Peripheral Nerve Sheath Tumor (Neurofibrosarcoma). According to...
Balstilimab by Agenus for Esophageal Cancer: Likelihood of Approval
Balstilimab is under clinical development by Agenus and currently in Phase II for Esophageal Cancer. According to GlobalData, Phase II...
Balstilimab by Agenus for Gastric Cancer: Likelihood of Approval
Balstilimab is under clinical development by Agenus and currently in Phase III for Gastric Cancer. According to GlobalData, Phase III...
Balstilimab by Agenus for Squamous Cell Carcinoma: Likelihood of Approval
Balstilimab is under clinical development by Agenus and currently in Phase II for Squamous Cell Carcinoma. According to GlobalData, Phase...